Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Patients with FLT3 Negative Acute Myeloid Leukemia and Normal Cytogenetic who Have the Combination Mutations (NPM1-/CEBPA-) Have Better Survival Than Patients Who Have the Combination Mutations (NPM1+/CEBPA+)

Shamail Butt, MD, Pascal Akl, MD, Himanshu Bhardwaj, MD, Samer A Srour, MB ChB, Terry Dunn, PHD, Shubham Pant, MD, Mohamad Ali Cherry, MD

Blood (2011) 118 (21): 4874.

https://doi.org/10.1182/blood.V118.21.4874.4874

Published: 2011

Journal Articles

Results of Autotransplantation in Follicular Large-Cell Lymphoma.

Edward A. Copelan, MD, Pamela Ann Crilley, DO, Brad Pohlman, MD, Patrick Elder, Shubham Pant, MD, Pallavi Marathe, MD, Isadore Brodsky, MD, Thomas S. Lin, MD, Brian J. Bolwell, MD

Blood (2006) 108 (11): 5458.

https://doi.org/10.1182/blood.V108.11.5458.5458

Published: 2006

Journal Articles

Long Term Follow-Up of Patients with Chronic Myeloid Leukemia Receiving BuCy2 as Preparation for Allotransplantation.

Edward A. Copelan, MD, Anthony J. Dodds, MBBS, Brian J. Bolwell, MD, Pamela Ann Crilley, DO, Patrick Elder, Shubham Pant, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, David Topolsky, MD, Ian Nivison-Smith, MAppSt, Belinda R. Avalos, MD, Jeffrey Szer, MBBS

Blood (2006) 108 (11): 3364.

https://doi.org/10.1182/blood.V108.11.3364.3364

Published: 2006

Journal Articles

Long-Term Follow-Up of Treatment for Acute Myeloid Leukemia with Allogeneic Hematopoetic Cell Transplantation Using BuCy2 as Preparation.

Shubham Pant, MD, Pamela Ann Crilley, DO, Anthony J. Dodds, FRACP, Jeffrey Szer, MBBS, Brian J. Bolwell, MD, Patrick Elder, Michael Styler, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Ian Nivison-Smith, MAppSt, Belinda R. Avalos, MD, Edward A. Copelan, MD

Blood (2006) 108 (11): 3370.

https://doi.org/10.1182/blood.V108.11.3370.3370

Published: 2006

Journal Articles

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Kiarash Kojouri, MD, MPH, Christian El-Khoury, MD, Shubham Pant, MD, Nancy Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5204.

https://doi.org/10.1182/blood.V104.11.5204.5204

Published: 2004

Journal Articles

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Christian El-Khoury, MD, Kiarash Kojouri, MD, MPH, Shubham Pant, MD, Nancy Sylvester-Kohrt, RN, George B. Selby, MD, Howard Ozer, MD, PhD, Rammurti Kamble, MD, Mohamed A. Kharfan-Dabaja, MD

Blood (2004) 104 (11): 5206.

https://doi.org/10.1182/blood.V104.11.5206.5206

Published: 2004

NARROW

Patients with FLT3 Negative Acute Myeloid Leukemia and Normal Cytogenetic who Have the Combination Mutations (NPM1-/CEBPA-) Have Better Survival Than Patients Who Have the Combination Mutations (NPM1+/CEBPA+)

Results of Autotransplantation in Follicular Large-Cell Lymphoma.

Long Term Follow-Up of Patients with Chronic Myeloid Leukemia Receiving BuCy2 as Preparation for Allotransplantation.

Long-Term Follow-Up of Treatment for Acute Myeloid Leukemia with Allogeneic Hematopoetic Cell Transplantation Using BuCy2 as Preparation.

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Email alerts

ASH Publications

American Society of Hematology

Patients with FLT3 Negative Acute Myeloid Leukemia and Normal Cytogenetic who Have the Combination Mutations (NPM1-/CEBPA-) Have Better Survival Than Patients Who Have the Combination Mutations (NPM1+/CEBPA+)

Results of Autotransplantation in Follicular Large-Cell Lymphoma.

Long Term Follow-Up of Patients with Chronic Myeloid Leukemia Receiving BuCy2 as Preparation for Allotransplantation.

Long-Term Follow-Up of Treatment for Acute Myeloid Leukemia with Allogeneic Hematopoetic Cell Transplantation Using BuCy2 as Preparation.

Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation (auto-BM/PSCT).

Evaluation of Body Mass Index (BMI) as a Prognostic Factor among Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation (Auto-BM/PSCT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only